Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
18.43
0.00 (0.00%)
At close: Oct 7, 2025
Apollomics Market Cap
Apollomics has a market cap or net worth of $39.56 million as of October 8, 2025. Its market cap has increased by 192.70% in one year.
Market Cap
39.56M
Enterprise Value
30.75M
1-Year Change
192.70%
Ranking
Category
Stock Price
$18.43
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $39.56M, a decrease of -69.47%. That is a compound annual growth rate of -26.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 39.56M | 267.97% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |